- CRDF Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Cardiff Oncology (CRDF) 10-Q/A2006 Q2 Quarterly report (amended)
Filed: 28 Dec 06, 12:00am
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
XENOMICS, INC.
FORM 10-Q/A FOR THE QUARTER ENDED JULY 31, 2006
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I am the Chief Financial Officer of Xenomics, Inc., a Florida corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q/A of the Company for the quarter ended July 31, 2006 and filed with the Securities and Exchange Commission (“Form 10-Q/A”).
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q/A fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of the Company.
December 28, 2006 | By: | /s/ Frederick Larcombe |
|
|
|
| Frederick Larcombe, |
|
|
|
| Chief Financial Officer |
|
|
|
| (Principal Financial and |
|
|
|
| Accounting Officer) |
|
|